SCHEMBL7073258

SCHEMBL7073258

CCc1ccccc1N/C=C1/C(=O)N(c2cccc(NC(=O)O)c2)N=C1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 12/20 0.45
MAPT P10636 10/20 0.45
MEN1 O00255 8/20 0.45
MAPK1 P28482 6/20 0.45
ALDH1A1 P00352 5/20 0.45
HTT P42858 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MDM2 Q00987 1/20 0.45
GPR55 Q9Y2T6 1/20 0.45
KAT8 Q9H7Z6 2/20 0.44
GAA P10253 1/20 0.43
KCNK3 O14649 1/20 0.42
KCNK9 Q9NPC2 1/20 0.42
KDM4E B2RXH2 2/20 0.42
L3MBTL1 Q9Y468 7/20 0.42
HSP90AA1 P07900 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 3/20 0.40
POLB P06746 2/20 0.40
NSD2 O96028 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7073259 1.00 KMT2A (0.45) KMT2AMAPTMEN1MAPK1ALDH1A1
SCHEMBL6947878 0.94 KMT2A (0.41) KMT2AMAPTMEN1MAPK1ALDH1A1
SCHEMBL6952715 0.94 KMT2A (0.41) KMT2AMAPTMEN1MAPK1ALDH1A1
SCHEMBL6951606 0.92 KMT2A (0.40) KMT2AMAPTMEN1MAPK1ALDH1A1
SCHEMBL6951611 0.92 KMT2A (0.40) KMT2AMAPTMEN1MAPK1ALDH1A1
SCHEMBL8424096 0.91 MAPT (0.43) KMT2AMAPTMEN1MAPK1ALDH1A1
SCHEMBL6942623 0.91 KMT2A (0.39) KMT2AMAPTMEN1MAPK1ALDH1A1
SCHEMBL6944929 0.91 KMT2A (0.39) KMT2AMAPTMEN1MAPK1ALDH1A1
SCHEMBL8424088 0.90 KMT2A (0.38) KMT2AMAPTMEN1MAPK1ALDH1A1
SCHEMBL8424092 0.90 KMT2A (0.38) KMT2AMAPTMEN1MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP claimed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US claimed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed